NO20030796D0 - Aza-aminosyrederivater (faktor Xa-inhibitorer 15) - Google Patents

Aza-aminosyrederivater (faktor Xa-inhibitorer 15)

Info

Publication number
NO20030796D0
NO20030796D0 NO20030796A NO20030796A NO20030796D0 NO 20030796 D0 NO20030796 D0 NO 20030796D0 NO 20030796 A NO20030796 A NO 20030796A NO 20030796 A NO20030796 A NO 20030796A NO 20030796 D0 NO20030796 D0 NO 20030796D0
Authority
NO
Norway
Prior art keywords
inhibitors
factor
amino acid
acid derivatives
aza amino
Prior art date
Application number
NO20030796A
Other languages
English (en)
Other versions
NO20030796L (no
Inventor
Werner Mederski
Horst Juraszyk
Dieter Dorsch
Christos Tsaklakidis
Johannes Gleitz
Christopher Barnes
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20030796L publication Critical patent/NO20030796L/no
Publication of NO20030796D0 publication Critical patent/NO20030796D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47Y being a hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/38Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
    • C07C317/42Y being a hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02Monothiocarbamic acids; Derivatives thereof
    • C07C333/04Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34Oxygen atoms
    • C07D317/40Vinylene carbonate; Substituted vinylene carbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
NO20030796A 2000-08-21 2003-02-20 Aza-aminosyrederivater (faktor Xa-inhibitorer 15) NO20030796D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040783A DE10040783A1 (de) 2000-08-21 2000-08-21 AZA-Aminosäurederivate (Faktor X¶a¶-Inhibitoren 15)
PCT/EP2001/009667 WO2002016315A1 (de) 2000-08-21 2001-08-21 AZA-AMINOSÄUREDERIVATE (FAKTOR Xa-INHIBITOREN 15)

Publications (2)

Publication Number Publication Date
NO20030796L NO20030796L (no) 2003-02-20
NO20030796D0 true NO20030796D0 (no) 2003-02-20

Family

ID=7653121

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030796A NO20030796D0 (no) 2000-08-21 2003-02-20 Aza-aminosyrederivater (faktor Xa-inhibitorer 15)

Country Status (19)

Country Link
US (1) US6849626B2 (no)
EP (1) EP1311476B1 (no)
JP (1) JP2004517811A (no)
KR (1) KR20030029810A (no)
CN (1) CN1469860A (no)
AR (1) AR030376A1 (no)
AT (1) ATE291012T1 (no)
AU (2) AU2001282113B2 (no)
BR (1) BR0113344A (no)
CA (1) CA2415838A1 (no)
CZ (1) CZ2003414A3 (no)
DE (2) DE10040783A1 (no)
ES (1) ES2238468T3 (no)
HU (1) HUP0303694A3 (no)
MX (1) MXPA03001555A (no)
NO (1) NO20030796D0 (no)
PL (1) PL360388A1 (no)
WO (1) WO2002016315A1 (no)
ZA (1) ZA200302252B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10036852A1 (de) * 2000-07-28 2002-02-07 Merck Patent Gmbh Urethanderivate
US6660737B2 (en) * 2001-05-04 2003-12-09 The Procter & Gamble Company Medicinal uses of hydrazones
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
RU2004129594A (ru) * 2002-03-04 2005-06-27 Мерк Патент ГмбХ (DE) Производные семикарбазидов и их применение как антитромботических агентов
DE10220048A1 (de) * 2002-05-04 2003-11-13 Merck Patent Gmbh Semicarbazidderivate
UY27813A1 (es) 2002-05-31 2003-12-31 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
TW200410921A (en) * 2002-11-25 2004-07-01 Hoffmann La Roche Mandelic acid derivatives
DE10325962A1 (de) 2003-06-07 2004-12-23 Merck Patent Gmbh Aroylsemicarbazidderivate
UA108596C2 (xx) 2007-11-09 2015-05-25 Інгібітори пептиддеформілази
JPWO2009096198A1 (ja) * 2008-02-01 2011-05-26 一般社団法人ファルマIp 新規ビアリール誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3285957A (en) * 1964-02-13 1966-11-15 Monsanto Co Diphenyl semicarbazides
KR20010023364A (ko) 1997-08-27 2001-03-26 간자와 무츠와 3-아미디노아닐린 유도체, 활성화 혈액응고 제 x 인자저해제 및 그것의 제조중간체

Also Published As

Publication number Publication date
JP2004517811A (ja) 2004-06-17
HUP0303694A3 (en) 2006-02-28
EP1311476A1 (de) 2003-05-21
DE50105634D1 (de) 2005-04-21
KR20030029810A (ko) 2003-04-16
MXPA03001555A (es) 2003-06-06
PL360388A1 (en) 2004-09-06
CN1469860A (zh) 2004-01-21
US20040034072A1 (en) 2004-02-19
DE10040783A1 (de) 2002-03-07
WO2002016315A1 (de) 2002-02-28
US6849626B2 (en) 2005-02-01
NO20030796L (no) 2003-02-20
EP1311476B1 (de) 2005-03-16
ATE291012T1 (de) 2005-04-15
HUP0303694A2 (hu) 2004-03-01
AR030376A1 (es) 2003-08-20
ES2238468T3 (es) 2005-09-01
BR0113344A (pt) 2003-07-15
CZ2003414A3 (cs) 2003-08-13
ZA200302252B (en) 2004-06-28
AU2001282113B2 (en) 2006-08-24
CA2415838A1 (en) 2002-02-28
AU8211301A (en) 2002-03-04

Similar Documents

Publication Publication Date Title
NO20041163L (no) Laktam-inneholdende forbindelser og derivater derav som faktor XA-inhibitorer
NO20021230D0 (no) Inhibitorer for faktor Xa
NO20013072L (no) Nitrogenholdige heterocykler som faktor Xa-inhibitorer
ATE243681T1 (de) Benzamidinderivate als faktor xa-inhibitoren
ATE346050T1 (de) Substituierte oxoazaheterocyclyl faktor xa hemmer
NO20026252D0 (no) AZA-broforbundet - bicykliske aminosyrederivater som alfa 4 integrin antagonister
NO20042592L (no) Indol-2-karboksamider som faktor XA inhibitorer
NO20011293D0 (no) Faktor VIIa-inhibitorer
GB0012850D0 (en) Cyclic amino acid derivatives useful as pharmaceutical agents
AU2002365896A8 (en) Substituted amino methyl factor xa inhibitors
GB0018828D0 (en) Alkyl Amino Acid Derivatives useful as pharmaceutical agents
DK1218383T3 (da) Biocykliske imidazo-5-yl-aminoderivater
NO20030796D0 (no) Aza-aminosyrederivater (faktor Xa-inhibitorer 15)
DE60203006D1 (de) Pyrrolidin-derivate als faktor xa inhibitoren
NO20042990L (no) Pyrrolidin-2-oner som faktor XA inhibitorer
DK1345900T3 (da) Guanidin- og amidinderivater som faktor XA-inhibitorer
DK1189929T3 (da) Faktor VIIa-inhibitorer
NO20014234D0 (no) Pyrazol-3-on-derivater som faktor-Xa-inhibitorer
AU3569801A (en) Amino acid derivatives and use thereof as nep, ace and ece inhibitors
DE60206376D1 (de) Faktor xa inhibitor
AU2002218233A1 (en) N-substituted amino acid derivatives (factor xa inhibitors)
PL357011A1 (en) Novel alpha-sulfin- and alpha-sulfonamino acid amide derivatives
FI20000395A (fi) N-(amidinobentsoyyli- tai amidinopyridyylikarbonyyli)-alfa-aminohappojohdannaisia
SI1255757T1 (en) Amino acid derivatives and use thereof as nep, ace and ece inhibitors
ITMI20000360A0 (it) Gel orale contenente composti aminoacidi solforati

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application